5 results
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... between oral agents ... (LD) in most cases ... oral agents in ... #conversion #Clopidogrel
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
BETWEEN AGENTS ... an alternative agent ... Doses should be ... #Pharmacology #Conversion ... #Table
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Repeat 12-milligram dose ... nodal blocking agents ... Treat underlying cause ... Treat underlying cause ... management #cardiology #algorithm
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding ... Agents to Treat ... 10 g QD (adjust dose ... aspiration #Potassium #Binding ... #pharmacology #table
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
Some exam findings ... adjusting the dose ... the determined cause ... #differential #algorithm ... cardiology #treatment #table